this is a beautiful Figure Romain Sonneville

👏 Prof Antonio Artigas is the recipient of this year's ESICM Society Medal. He is a founding member of ESICM & his dedication & expertise over +40 years have allowed him to witness the evolution of #CriticalCare medicine & remain an active participant in its advancement.

The ESICM VITAL project to improve #ICU care just launched at #LIVES2023 📢 Voice of patients & family members 🌈 Inclusion, diversity, empowerment 🤝Together, partnership, value 🛟 Alliance:collaboration 🔗 Linking: creating peer community #togetherweareICU but with patients,

👇Free access to our methylene blue meta-analysis recently published in Journal of Cardiothoracic and Vascular Anesthesia Additional evidence in favor of multimodal vasopressor therapy✨ 🔓authors.elsevier.com/c/1hzYp3lSIPuA… #FOAMcc

Second day of ESICM EuroELSO #ECMO #simulation workshop is about to start here in Milan at #LIVES2023!! #simulation training tomorrow 🩸cannulation 🫁 veno-venous #ECMO & 🫀veno-arterial #ECLS scenarios ⚙️ #extracorporeal circuit & troubleshooting complications

AKI #LIVES2023 #ESICM Katia Donadello Eric Hoste John Prowle: serum creatinine is an inappropriate measure in our patient cohort NB- Creatinine in Spinal Injury patients hopeless! #NeuroICM #AKI

If we can make reviewers smile😄, we will be able to smile 😊 How to deal with reviewers' comments and successful publication By @PPovoa3

How to use Social Media to promote your research. Great talk at #LIVES2023 by Marta Velia Antonini M Velia Antonini ESICM

RRT workshop during ESICM Lives 2023 (and the coffee break ☕️)

Presented at #LIVES2023: In this open-label, randomized trial in patients newly receiving mechanical ventilatory support for Covid-19–associated ARDS, those who received convalescent plasma had lower 28-day mortality than those who received standard care. Full study:

Presented at #LIVES2023: In a randomized trial involving critically ill patients who had undergone mechanical ventilation for 3 days, a 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia. Full AMIKINHAL trial results: nej.md/472lySJ

📣 2 major new REMAP-CAP papers were released moments ago! 📄 Intravenous #VitaminC for Patients Hospitalized with #COVID19: Two Harmonized Randomized Clinical Trials 👉 jamanetwork.com/journals/jama/… 📄 #Simvastatin in Critically Ill Patients with COVID-19 👉 nejm.org/doi/full/10.10…

Convalescent Plasma for Covid-19 ARDS decreased 28 day mortality NEJM ESICM

🫁Convalescent plasma against COVID-19 reduced mortality in COVID-19 patients on mechanical ventilation. Proud to have been part of this Belgian PRCT run by Benoit Misset and presented at #LIVES2023 🔓tinyurl.com/yat4aru4 ESICM NEJM @KCEfgov Rode Kruis-Vlaanderen

The first participant was enrolled in the LIMIT trial - RCT comparing Low and Medium Intensity CRRT. Significant step forward😀

Our new publication in Critical Care🍾 How often is significant mortality reduction in single-center trials replicated by subsequent multicenter trials? Even if you consider monocentric trials published in NEJM/JAMA/Lancet, the probability is only 6%😱 🔓doi.org/10.1186/s13054…

🏆 Top cited Intensive Care Medicine articles published this year 🥈 with 20 citations in 2023 (really close to 1st place) 🧫EuroBACT-II study on hospital‑acquired bloodstream infections in #ICU, including 2600 pts, 699 contributors from 333 ICUs/52 countries #FOAMcc 🔓 rdcu.be/c5nEP

A selection of 2023's highlighted research ! 🔝🔥🔥

For World Kidney Day can we please FIX THE MATH Int Society of Nephrology claims only 13m people sustain AKI annually but it's really about 100m. In the US about 11% of hospitalizations have AKI or about 90 per 10,000 person yrs. If we include AKD, rates are above 130 per 10,000 person yrs

Last week, this marvelous team celebrated 1500 liver transplantations in UZ Gent. Expertise, engagement and most of all collaboration are key for success.